Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05873465
Other study ID # 15416
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date March 14, 2023
Est. completion date June 30, 2025

Study information

Verified date June 2024
Source University of Oklahoma
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The use of Cannabis is increasing in the population, and the effects that this might have on different medical procedures are poorly understood. Particularly when submitted to deep sedation or general anesthesia, there is no consensus on best drugs or doses to deliver. The purpose of this clinical trial is to clarify the influence of chronic cannabis use during office based general anesthesia for extraction of teeth. The procedures will be performed in the Oral and Maxillofacial Surgery Clinic at the College of Dentistry.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date June 30, 2025
Est. primary completion date May 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients older than 18 years of age - Class I or II according to the American Society of Anesthesiology (ASA) - Need for dental extractions - Extraction procedures with similar level of complexity Exclusion Criteria: - Surgical time lesser than 10 or greater than 30 minutes - ASA status of III or greater - BMI greater than 30 k/m2 - Pregnancy - Use of anti-depressants, sedatives, or other mood-altering medications - History of illicit substance abuse, alcoholism, or chronic opioid use

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Sedation with Midazolam, Fentanyl, and Propofol
Patients will have teeth extracted under sedation with Midazolam, Fentanyl, and Propofol
Procedure:
Extraction of teeth
The necessary teeth will be extracted

Locations

Country Name City State
United States College of Dentistry Oklahoma City Oklahoma

Sponsors (1)

Lead Sponsor Collaborator
University of Oklahoma

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Propofol dose in milligrams Compare the total amount of propofol necessary to sedate patients that use cannabis with patients that do not use During the procedure
Secondary Heart rate in beats per minute Compare how the heart rate behave during the procedure in each group During the procedure
Secondary Blood pressure in millimeters of mercury Compare how the blood pressure behave during the procedure in each group During the procedure
Secondary Quality of sedation grading from 0 to 6 according to the Observer's Assessment of Alertness/Sedation scale Compare the difference in sedation quality during the procedure in each group During the procedure
See also
  Status Clinical Trial Phase
Completed NCT03253926 - Effect of Lorcaserin on Cannabis Withdrawal and Self-administration Phase 1/Phase 2
Completed NCT04060602 - Personalized Feedback Intervention to Reduce Risky Cannabis Use. N/A
Completed NCT01212081 - Assessment of Cannabis Craving in Schizophrenia Using Virtual Reality
Recruiting NCT04988490 - Quantification of Cannabinoids and Comparison to Post-Surgical Pain Medication Requirements and Surgical Outcomes
Recruiting NCT05188404 - Aging and Marijuana: Benefits, Effects, and Risks
Completed NCT03662737 - VRT as a Biomarker of Cerebellar Dysfunction in Chronic Cannabis Use
Not yet recruiting NCT05999383 - Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration Phase 2
Terminated NCT04436055 - Intergenerational Effects of Paternal Periconceptional Cannabis and Other Drug Use (EPIC)
Active, not recruiting NCT04374773 - Effects of Pregnancy-associated Hormones on THC Metabolism in Women Phase 4
Completed NCT04316741 - Brief Intervention Combined With Health Coaching Via Social Media for Cannabis Use N/A
Recruiting NCT05396638 - Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder N/A
Recruiting NCT05309226 - Cannabis Use in Pregnancy and Downstream Effects on Maternal and Infant Health
Recruiting NCT03859089 - Cannabis for Opioid Substitution Trial
Recruiting NCT05849636 - Alerta Cannabis: Evaluation of Web-based Tailored Intervention N/A
Enrolling by invitation NCT05521321 - Feasibility and Acceptability of the Cannabis Awareness and Prevention Toolkit N/A
Recruiting NCT05119244 - Environment and Lung Cancer N/A
Recruiting NCT04841655 - Tobacco Cessation Among Smokers Under Alcohol and/or Cannabis Treatment
Terminated NCT04100590 - Eye Tracking as a Biomarker of Cannabis Effects Phase 2
Completed NCT05167097 - Mindsets and the Effectiveness of a Brief Intervention - Replication N/A
Recruiting NCT04114903 - Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity